C3a Receptor Signaling Inhibits Neurodegeneration Induced by Neonatal Hypoxic-Ischemic Brain Injury

Area of Science:

• Neuroscience
• Developmental Biology
• Immunology

Background:

• Hypoxic-ischemic encephalopathy (HIE) is a major cause of newborn brain injury.
• Brain inflammation from perinatal insults can lead to chronic neurological deficits.
• Complement C3a receptor (C3aR) signaling previously showed protective effects against HIE-induced cognitive impairment.

Purpose of the Study:

• To examine the long-term neuropathological consequences of HIE in the developing brain.
• To elucidate the role of C3aR signaling in HIE-induced long-term brain injury.
• To evaluate therapeutic strategies targeting C3aR for HIE.

Main Methods:

• Mild hypoxic-ischemic brain injury was induced in wildtype, C3aR-deficient, and C3a-expressing mice on postnatal day 9.
• Long-term neuropathological assessments included neurodegeneration and reactive gliosis in the hippocampus.
• Therapeutic interventions involved transgenic C3a expression and intranasal C3a administration.

Main Results:

• HIE induced persistent neurodegeneration and reactive gliosis in the hippocampus into adulthood.
• Transgenic C3a expression in astrocytes mitigated neurodegeneration and gliosis.
• C3aR deficiency exacerbated neurodegeneration and increased microglial density.
• Intranasal C3a treatment reduced HIE-induced hippocampal damage in wildtype mice.

Conclusions:

• Neonatal HIE results in enduring neurodegeneration.
• C3aR signaling plays a critical role in modulating the long-term neuropathological sequelae of HIE.
• C3aR agonists represent a promising therapeutic strategy for mitigating HIE-induced brain injury.